Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript August 7, 2023 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.00058 EPS, expectations were $0.56. Operator: Thank you for standing by, and welcome to Cara Therapeutics’ Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. […]

Related Keywords

Japan ,Germany ,United States ,America ,Joana Goncalves ,Bryan Maynard ,Piper Sandler ,Jason Gerberry ,Us Ryan Maynard ,David Amsellem ,Annabel Samimy ,Scott Terrillion ,Canaccord Genuity ,Igor Kardasov Shutterstock ,Chi Fong ,Christopher Posner ,Sumant Kulkarni ,Chris Posner ,England National Institute For Health ,Joseph Stringer Of Needham Company ,Fresenius ,Biggest Internet Of Things Companies ,European Commission ,Head Of Government Affairs ,Chief Executive ,Chief Financial Officer ,Chief Medical Officer ,General Counsel ,National Institute ,Care Excellence ,Things Companies ,Paid Medical Specialties ,Dennis Ding ,North Star ,Joseph Stringer ,Whati M ,Cara Therapeutics ,023 Cara Therapeutics ,Nc ,Perator Instructions ,Matt Murphy ,Korsuva ,